Merck is a massive company with strong fundamentals and underlying value at a heavily discounted price. Click here to find ...

The Business Research Company's The Specific Antiviral Drugs For COVID 19 Market Forecast To 2034 – For Business Leaders, Analysts, And Strategic Teams It will grow to $28.43 billion in 2029 at a ...

Imagine a world without disease. Sounds utopian? AI just made it a multibillion-dollar bet to discover drugs – and forget Big ...

Guidelines aimed at increasing transparency about how the regulator will evaluate pharmaceutical pricing, official says ...

As if to address the concerns of both groups, Kennedy's FDA announced in May that it approves covid boosters only for those over 65 or in other high-risk groups. The vaccine remains available to ...

The new vaccine committee appointed by Secretary Robert F. Kennedy Jr. took minimal action in its first meeting.

The African Pharmaceutical Market is projected to grow at an impressive CAGR of 6-8% by 2029, driven by a booming population, ...

In this week’s edition of InnovationRx, we look at the health impact of the Republican spending bill, a startup that built a hospital in India to test its AI software, the impact of the vaccine panel ...

Following is a summary of current health news briefs. US open to 'creative solutions' on pharma trade with EU, Irish minister says. U.S. Trade Representative Jamieson Greer made c ...

Merck is acquiring Verona Pharma for $10 billion, gaining COPD drug Ohtuvayre as part of its strategy to offset Keytruda's ...